Literature DB >> 26768026

Phyllodes tumours of the breast: a consensus review.

Benjamin Y Tan1, Geza Acs2, Sophia K Apple3, Sunil Badve4, Ira J Bleiweiss5, Edi Brogi6, José P Calvo7, David J Dabbs8, Ian O Ellis9, Vincenzo Eusebi10, Gelareh Farshid11, Stephen B Fox12, Shu Ichihara13, Sunil R Lakhani14, Emad A Rakha9, Jorge S Reis-Filho6, Andrea L Richardson15, Aysegul Sahin16, Fernando C Schmitt17, Stuart J Schnitt18, Kalliopi P Siziopikou19, Fernando A Soares20, Gary M Tse21, Anne Vincent-Salomon22, Puay Hoon Tan1.   

Abstract

Phyllodes tumours constitute an uncommon but complex group of mammary fibroepithelial lesions. Accurate and reproducible grading of these tumours has long been challenging, owing to the need to assess multiple stratified histological parameters, which may be weighted differently by individual pathologists. Distinction of benign phyllodes tumours from cellular fibroadenomas is fraught with difficulty, due to overlapping microscopic features. Similarly, separation of the malignant phyllodes tumour from spindle cell metaplastic carcinoma and primary breast sarcoma can be problematic. Phyllodes tumours are treated by surgical excision. However, there is no consensus on the definition of an appropriate surgical margin to ensure completeness of excision and reduction of recurrence risk. Interpretive subjectivity, overlapping histological diagnostic criteria, suboptimal correlation between histological classification and clinical behaviour and the lack of robust molecular predictors of outcome make further investigation of the pathogenesis of these fascinating tumours a matter of active research. This review consolidates the current understanding of their pathobiology and clinical behaviour, and includes proposals for a rational approach to the classification and management of phyllodes tumours.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  classification; fibroadenoma; malignant; metastasis; phyllodes

Mesh:

Year:  2016        PMID: 26768026      PMCID: PMC5027876          DOI: 10.1111/his.12876

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  125 in total

1.  Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.

Authors:  Erika Resetkova; Laila Khazai; Constance T Albarracin; Elsa Arribas
Journal:  Breast J       Date:  2010 Nov-Dec       Impact factor: 2.431

Review 2.  Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors.

Authors:  R J Barth
Journal:  Breast Cancer Res Treat       Date:  1999-10       Impact factor: 4.872

3.  Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.

Authors:  T Moore; A H Lee
Journal:  Histopathology       Date:  2001-01       Impact factor: 5.087

4.  A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil.

Authors:  Juliana Giacomazzi; Patricia Koehler-Santos; Edenir Inez Palmero; Marcia S Graudenz; Luis Fernando Rivero; Eduardo Lima; Antonio Carlos Kruel Pütten; Pierre Hainaut; Suzi Alves Camey; Rodrigo Depieri Michelli; Cristovam Scapulatempo Neto; Mariana Fitarelli-Kiehl; Geraldo Geyer; Luise Meurer; Ana Geiger; Monica Blaya Azevedo; Vinicius Duval da Silva; Patricia Ashton-Prolla
Journal:  Virchows Arch       Date:  2013-06-21       Impact factor: 4.064

Review 5.  Close/positive margins after breast-conserving therapy: additional resection or no resection?

Authors:  William C Wood
Journal:  Breast       Date:  2013-08       Impact factor: 4.380

6.  Immunohistochemical profile of phyllodes tumors of the breast.

Authors:  Y Singh; T Hatano; Y Uemura; N Shikata; H Senzaki; K Hioki; A Tsubura
Journal:  Oncol Rep       Date:  1996-07       Impact factor: 3.906

7.  Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.

Authors:  Hui Wang; Xiang Wang; Cheng-Feng Wang
Journal:  Asian Pac J Cancer Prev       Date:  2014

8.  Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.

Authors:  Edwin O Onkendi; Rafael E Jimenez; Grant M Spears; William S Harmsen; Karla V Ballman; Tina J Hieken
Journal:  Ann Surg Oncol       Date:  2014-07-18       Impact factor: 5.344

9.  An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.

Authors:  Barbara Dunne; Andrew H S Lee; Sarah E Pinder; Jane A Bell; Ian O Ellis
Journal:  Hum Pathol       Date:  2003-10       Impact factor: 3.466

10.  Frequent MED12 mutations in phyllodes tumours of the breast.

Authors:  M Yoshida; S Sekine; R Ogawa; H Yoshida; A Maeshima; Y Kanai; T Kinoshita; A Ochiai
Journal:  Br J Cancer       Date:  2015-04-02       Impact factor: 7.640

View more
  74 in total

1.  Morphologic and genetic heterogeneity in breast fibroepithelial lesions-a comprehensive mapping study.

Authors:  Benjamin Yongcheng Tan; Nur Diyana Md Nasir; Huan Ying Chang; Cedric Chuan Young Ng; Peiyong Guan; Sanjanaa Nagarajan; Vikneswari Rajasegaran; Jing Yi Lee; Jing Quan Lim; Aye Aye Thike; Bin Tean Teh; Puay Hoon Tan
Journal:  Mod Pathol       Date:  2020-04-22       Impact factor: 7.842

2.  Primary breast leiomyosarcoma and synchronous homolateral lung cancer: a case report.

Authors:  Alberto Testori; Stefano Meroni; Emanuele Voulaz; Marco Alloisio; Rita De Sanctis; Paola Bossi; Umberto Cariboni; Matilde De Simone; Ugo Cioffi
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

3.  Clinical breast concerns in low-risk pediatric patients: practice review with proposed recommendations.

Authors:  Linda M Sanders; Pinky Sharma; Miriam El Madany; Alexander B King; Koren S Goodman; Alison Esteva Sanders
Journal:  Pediatr Radiol       Date:  2017-10-27

4.  Malignant Phyllodes of Breast.

Authors:  Cha Kyong Yom
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Benign Breast Disease in Women.

Authors:  Angrit Stachs; Johannes Stubert; Toralf Reimer; Steffi Hartmann
Journal:  Dtsch Arztebl Int       Date:  2019-08-09       Impact factor: 5.594

6.  A Huge Benign Phyllodes Tumour of the Breast: a Rare Entity.

Authors:  Jeetendar Paryani
Journal:  Indian J Surg Oncol       Date:  2019-03-27

7.  Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis-generating study.

Authors:  John R Lozada; Kathleen A Burke; Aoife Maguire; Fresia Pareja; Raymond S Lim; Jisun Kim; Rodrigo Gularte-Merida; Melissa P Murray; Edi Brogi; Britta Weigelt; Jorge S Reis-Filho; Felipe C Geyer
Journal:  Histopathology       Date:  2017-07-05       Impact factor: 5.087

8.  ASO Author Reflections: Malignant/Borderline Phyllodes Tumors Without Uniformly Poor Histologic Features Have an Excellent Prognosis.

Authors:  Philip M Spanheimer; Andrea V Barrio
Journal:  Ann Surg Oncol       Date:  2019-05-20       Impact factor: 5.344

9.  Size and heterologous elements predict metastases in malignant phyllodes tumours of the breast.

Authors:  Valerie Cui Yun Koh; Aye Aye Thike; Nur Diyana Md Nasir; George Wai Cheong Yip; Boon Huat Bay; Puay Hoon Tan
Journal:  Virchows Arch       Date:  2017-11-10       Impact factor: 4.064

Review 10.  Fibroepithelial lesions revisited: implications for diagnosis and management.

Authors:  Puay Hoon Tan
Journal:  Mod Pathol       Date:  2020-05-27       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.